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and to elucidate if EGFR, MMP-1, MMP-9 and VEGF could be involved in its therapeutic 27 mechanism. 28 A mouse model of MRSA skin infection was established. Mice were treated daily with vancomycin 29 (10mg/kg) and weekly with dalbavancin, at day 1 (20 mg/kg) and day 8 (10 mg/kg). After 14 days 30 wounds were excised and bacterial counts were perfomed. Wound healing was assessed by 31 histological and immunohistochemical staining, followed by protein extraction and immunoblotting. 32
Our microbiological results confirmed that both dalbanvancin and vancomycin are effective in 33 reducing the bacterial load in wounds. Dalbavancin had a strong effect compared with infected 34 untreated animals and vancomycin treated group. The wounds treated with dalbavancin showed 35 robust epidermal coverage with a reconstitution of the regular and keratinized epidermal lining and 36 a well-organized granulation tissue with numerous blood vessels, although slightly less than in the 37 uninfected group, while in vancomycin treated group the epithelium appeared in general still 38 hypertrophic, the granulation tissue appears even less organized. 39
We observed elevated EGFR and VEGF expression in both treated groups, although it was higher 40 in dalbavancin treated mice. MMP-1 and MMP-9 were decreased in uninfected and in both treated 41 tissue when compared with untreatd infected wounds. 42
This study showed faster healing with dalbavancin treatment that might be associated with a higher 43 EGFR and VEGF levels. 44
INTRODUCTION 45
It has recently proposed a new classification of skin and soft tissue infections namely acute bacterial 46 skin and skin structure infections (ABSSSIs) where Superficial incisional Surgical Site Infections or 47 SSIs (involving only skin or subcutaneous tissue of the incision) are recognized a subgroup 48
ABSSSIs (1) . In particular SSIs constitute a significant burden for the healthcare system, because of 49 the associated morbidity, mortality, length of hospital stay, a higher probability of intensive care 50 unit (ICU) admission with overall direct and indirect costs (2). 51
The common pathogens that are resposible of SSI are Staphylococcus aureus, followed by 52
Coagulase-negative staphylococci and Enterococcus species. In particular methicillin-resistant 53
Staphylococcus aureus (MRSA) is considered a leading cause of human nosocomial infections (3) 54 as well as community-associated MRSA (CA-MRSA) is associated to deadly infection (4) and 55 livestock-associated MRSA (LA-MRSA) represent major reservoir of infection (5). 56
In the last decades the epidemiological aspects of nosocomial infection as well as the growing 57 prevalence of CA-MRSA have been increasingly studied to conteract this worldwide public health 58 problem. Particular attention has been paid to the problem of LA-MRSA. Several studies 59 demonstrated that this superbug can be trasmitted to human by either healthy and disease animals, 60 usually cow, horses and companion animals (6-7). 61
Taking into account these considerations, the respect of the principles of a good antibiotic 62 stewardship is mandatory for fighting antimicrobial resistance and aim, next to optimization of 63 clinical outcomes, to the prevention of the spread of antibiotic-resistant strains (8 Gram-positive organisms (9). Moreover, it has a bactericidal effect and an extremely extended half-69 life that make it a promising alternative to conventional antibacterials such as vancomycin, that is 70 considered the standard of care for treatment of gram-positive skin and soft-tissue infections (10). 71
Wound healing is a highly complex physiological process involving ordered events where 72 growth factors are critically important for coordinating cell-cell and cell-matrix interactions during 73 normal injury repair. In particular Epidermal keratinocytes (KCs) respond to injury by becoming 74 hyperproliferative, migratory and pro-inflammatory in processes regulated by several factors such 75 as epidermal growth factor receptor (EGFR), a 170-kDa transmembrane protein belonging to ErbB 76 family receptors, which includes three other members (ErbB2/HER-2, ErbB3/HER-3, ErbB4/HER-77 4). EGFR signaling plays key roles in skin regeneration and wound healing by stimulating KCs 78 proliferation (11). Among the many proteins, that are essential for the restoration of tissue integrity, 79 the metalloproteinase family is one of the most important. Matrix metalloproteinases (MMPs) 80 comprise a large family of extracellular proteases, which are up-regulated during wound healing by 81 epidermal, dermal, fibroblast, or blood cells in mammals (12). MMPs contribute significantly in 82 reorganization of the extracellular matrix for numerous physiological functions including 83 morphogenesis, tissue remodeling and wound healing (13). In particular MMP-1 and MMP-9 84 reflect the correlation between high protease activity and poor healing outcomes (12). 85
An essential feature of normal wound repair is the formation of granulation tissue, i.e. fibrovascular 86 tissue containing fibroblasts, collagen and blood vessels. Vascular endothelial growth factor (VEGF) 87 has shown to be important in wound healing by promoting the early events in angiogenesis, 88 particularly endothelial cell migration and proliferation (14). VEGF is produced by endothelial cells, 89 keratinocytes, fibroblast, smooth muscle cells, platelets, neutrophils and macrophages 15 , and, 90 although in normal skin is negligible, in injured skin is markedly up-regulated (14-16). 91
This study aimed to explore the therapeutic effects of dalbavancin on wound healing in an infected 92 MRSA mouse model, using histological, immunohistochemial and western blot analysis, and to 93 elucidate if EGFR, MMP-1, MMP-9 and VEGF could be involved in its therapeutic mechanisms. 94 5 95 RESULTS 96
Bacterial Counts 97
Overall, data analysis showed that inhibition of bacterial growth was achieved in all treated groups. 98
In details, mean bacterial numbers in untreated group (7,51 x10 8 ± 5,05 x10 7 CFU/ml) were 99 significantly higher than those recovered from all treatment groups (Fig. 1 ). Treatment with 100 vancomycin reduced the mean bacterial numbers to 8,04 x10 6 ± 7,96 x 10 6 CFU/ml, while 101 dalbavancin had a strong effect compared with control infected untreated animals and vancomycin 102 treated group (8,71 x 10 5 ± 9,02 x 10 5 CFU/ml). 103
Histological evaluation 104
To investigate the effects of the different treatments on wound healing, we analyzed the area of the 105 wound, in particular reepithelialization, granulation tissue, collagen deposition and inflammatory 106 cells according to wound healing scores 20 summarized in Table1. The statistical analysis was 107 reported in Table 2 and the morphological features was shown in Figure 2 . 108
The extent of newly formed epithelium and collagen deposition, the increase in the thickness of 109 granulation tissue and the decrease in the number of inflammatory cells were considered as progress 110 in the healing process. 111
Wound healing was still incomplete in the untreated groups, as observed by the partial regeneration 112 of the epidermis, poor organization of dermis layers, immature granulation tissue (many cells and 113 some fibers), and abundant inflammatory infiltrate. These mice showed the worst degree of healing 114 (p<0.05). 115
From a microscopic examination, the neo-epithelium developed significantly different patterns of 116 regeneration among the treated groups: interestingly, the re-epithelialization of the wounds treated 117 with dalbavancin showed robust epidermal coverage with a reconstitution of the regular and 118 keratinized epidermal lining, comparable to the re-epithelialization of the uninfected mice, except in 119 a small central area where the epithelium appears to be hypertrophic. The wounds treated with 120 vancomycin showed a good re-epithelialization, although the epithelium appeared in general still 121 hypertrophic when compared to dalbavancin and uninfected groups (p<0.05). 122
The wounds treated with dalbavancin showed a well-organized granulation tissue with numerous 123 blood vessels, although slightly less than in the uninfected group. In the wounds treated with 124 vancomycin the granulation tissue appears even less organized. 125
The treated wounds presented a distinct pattern of collagen distribution and remodeling similar to 126 that of uninfected skin; in addition, mild or moderate inflammation was observed in the underlying 127 connective tissue. 128
Immunohistochemical evaluation 129
To investigate the influence of the dalbavancin and vancomycin treatment on the expression of 130 VEGF, EGFR, MMP-9 and MMP-1 and in wound healing, an immunhistochemical evaluation was 131 performed. The immunohistochemical staining is shown in Figures.3-4 . and the data are 132 summarized inTable.3. 133 VEGF expression was greater in the uninfected and treated infected groups respect to the untreated 134 (p<0.05), the wounds treated with dalbavancin showed the highest VEGF values. 135 EGFR expression was significantly higher in the uninfected and infected group treated with 136 dalbavancin respect to the other two groups (p<0.05), the wounds treated with dalbavancin showed 137 the highest expression. 138 MMP-9 and MMP-1 expression was high in the untreated infected wounds, while a significant 139 reduced expression was found in the other groups (p<0.05), in particular the treated wounds showed 140 the lowest values. 141
Analysis by Western blot of the Expression of EGFR, VEGF, MMP-1and MMP-9 142
The expression of EGFR, VEGF, MMP-1 and MMP-9 was tested by Western blot followed by 143 densitometric analysis ( After external skin injury, such as chirurgical intervention, a rapid repair is needed to avoid 178 dehydration and blood loss. Thus, a wound healing process involves a coordinated cascade of 179 events comprising inflammation, formation of granulation tissue and dermis maturation (27-28). 180
It has been shown that the bacteria are specifically able to alter stromal components and 181 inflammatory cells and their responses. Infact, Human stromal cells demonstrated, to be susceptible 182 to soluble factors of S. aureus, biofilms, decreasing cell differentiation, viability, migration and 183 angiogenesis (29). Therefore S. aureus showed to have a dramatic effect on keratinocyte 184 proliferation rates as well as an impedance to the migration of the keratinocytes, evidenced by 185 delayed wound closure (30). Thus, we studied the effect of dalbanvancin vs vancomycin on the 186 infected MRSA wound healing process through morphological studies besides an 187 immunoistochemical evidences; moreover, to confirm our results we performed a western blot 188
analysis. 189
As expected, in the infected but untreated groups, wound healing was still incomplete, with partial 190 regeneration of the epidermis, poor organization of dermis layers, immature granulation tissue, and 191 abundant inflammatory infiltrate. Both treatments showed to be efficacy on wound healing process. 192
In particular, in dalbavancin treated group we observed a robust epidermal coverage with a 193 reconstitution of the regular and keratinized epidermal lining, while epidermis in vancomycin 194 treated group was still hypertrophic, revealing that epithelial healing problem is still occurring. 195 Besides, in the present study we discovered elevated EGFR expression in the treated groups, 196
although it was higher in dalbavancin treated mice. These immunohistochemical results correlated 197 with the histological features and suggested that dalbavancin and vancomycin were able to induce 198 EGFR expression and consequently to have an effect on wound healing. In particular, dalbavancin 199 seemed to be more effective than vancomycin in inducing reepithelialization. 200
Epidermal keratinocytes are a rich source of EGFR ligands, and EGFR signaling has a major effect 201 on the proliferation and differentiation of keratinocytes. Therefore, EGFR plays a key role in skin 202 development and homeostasis (31) and its expression in the epithelium is a good indicator of the 203 healing potential as observed in previuos studies (32, 14) . In our study MMP-1 and MMP-9 were 204 decreased in uninfected and in both treated tissues, when compared with untreatd infected wounds. 205
It has demonstrated that these metalloproteinases play a pivotal role, with their inhibitors, in 206 regulating extracellular matrix (ECM) degradation and deposition that is essential for wound 207 reepithelialization (33). 208
While, in normal tissue, MMPs are expressed at basal levels, when tissue remodeling is required (as 209 in wound healing), they can be rapidly expressed and activated. Therefore, MMPs are upregulated 210 during wound healing in the very early stages in epidermal cells, dermal cells, fibroblasts and blood 211 cells (12). 212
Infact, it has been shown that MMP-1 expression peaks at day 1 after wounding in migrating basal 213 keratinocytes at the wound edge followed by a gradual decrease until re-epithelialization is 214 complete. Downregulation of MMP-1 seems to be important for normal tissue remodeling as high 215 levels of MMP-1 in chronic nonhealing wounds are described (33). Similarly migrating 216 keratinocytes at the leading edges secrete MMP-9, that modulate keratinocyte motility by 217 degradation of proteins involved in cell-cell and cell-matrix adhesion, allowing re-epithelialization 218 to occur (33). In particular, MMP-9 knockout (KO) mice, and MMP-9-deficient mice showed 219 delayed wound closure with inhibition of cell proliferation (34-35), whereas the persistence of high 220 level of MMP-9 has been associated with poor healing in several studies (36-38). These findings 221 highlighted the role of MMP-9 in wound healing. In addition, when the balance of MMPs activitiy 222 and ihnibition is disturbed the wound progress to a state of increased ECM degradation, disrupting 223 the equilibrium of synthesis and remodeling of ECM components, determinant for succesful skin 224 repaired (39). It is well known that MMPs play also a significant role in stimulation of angiogenesis 225 in the proximity of wounds to accelerate recovery (33). In particular, the role of MMP-9 in 226 angiogenesis include VEGF release (40-41). Actually, VEGF and MMP seem to regulate each other, 227 contributing to wound repair (42). Previous studies have evidenced that keratinocytes express 228 elevated VEGF as early as 1 day after injury and eventually in those cells that migrate to cover the 229 defect. Epidermal labeling for VEGF mRNA reaches a peak after 2-3 days, and levels remain 230 elevated during the granulation tissue formation and until epidermal coverage is complete (43). In 231 this period, VEGF is upregulated to promote the angiogenesis (i.e., vascular dilation, permeability, 232 migration, and proliferation), providing a conduit for nutrients and other mediators of the healing 233 response (43). In our study we observed that VEGF expression was highly expressed in the 234 uninfected and both treated infected groups, although the wounds treated with dalbavancin showed 235 the highest VEGF values, underlining the positive effect of dalbavancin on angiogenesis. 236
In conclusion it can be speculated that both treatments may have positive effect not only on the 237 bacterial load, but also on tissue healing after surgical infected skin wound by downregulation of 238 MMP-1 and MMP-9 and increase of EGFR and VEGF expression. In particular this study showed 239 faster healing with dalbavancin treatment that might be associated with a higher EGFR and VEGF by culturing serial dilutions of the bacterial suspension on mannitol-salt agar plates at 37°C for 24-292 48 hours. The limit of detection for this method was approximately 10 CFU/ml. 293
Histological and immunohistochemical staining 294
To understand the efficacy of the treatments in promoting wound healing, the re-epithelialized 295 tissue of each group was investigated histologically. Five micrometer thick sections were stained 296 with hematoxylin and eosin (H&E) according to standard protocol. The stained sections were 297 observed under the light microscope (Nikon DS-Vi1, Nikon Instruments, EuropeBV, Kingston, 298 Surrey, England) and scored according to wound repair fivetiered grading system based on 299 epithelial presence, degree of stratification, degree of differentiation as well as maturational features 300 of the granulation tissue, dermal tissue and presence of inflammatory cells (46) ( Table.1) . 301
In addition, identification of VEGF, MMP-1, MMP-9 and EGFR expression was carried out using 302 immunohistochemistry of histological samples with a heat-mediated antigen retrieval process. 303
Briefly, 5 μm paraffin sections were deparaffinized and rehydrated by sequential immersion in 304 xylene, ethanol, and water. Antigen retrieval was carried out by heating the sections in 0.1 M citrate 305 buffer solution (pH 6.0) at 98 °C for 5 min via microwave. Then they were incubated with 306 monoclonal anti-mouse VEGF (clone C-1; Santa Cruz Biotechnologies, Santa Cruz, CA), MMP-1 307
(clone H-300; Santa Cruz Biotechnologies, Santa Cruz, CA ), MMP-9 (clone 2C3; Santa Cruz 308 Biotechnologies, Santa Cruz, CA) and EGFR (clone 1005; Santa Cruz Biotechnologies, Santa Cruz, 309 CA) at 4 °C overnight and immunostained using the streptavidin-biotin peroxidase technique 310 (Envision universal peroxidase kit; Dako Cytomation, Milan, Italy). After incubation, the tissue 311 sections were colored with 3,3-diaminobenzidine (DAB), stained with hematoxylin, and 312 coverslipped with Eukitt mounting medium (Electron Microscopy Sciences, PA, USA). 313
Two investigators (G.L., A.Z.) blinded to the mice outcome, performed all counts separately. We 314 counted the number of marker positive cells by using a light microscope (Nikon Eclipse E 600, 315
Nikon Instruments, Europe B.V., Amsterdam, Netherlands) at x200 magnification in at least ten 316 fields/sample and the positive cells were expressed as mean value ± standard deviation (SD). 317
Images were captured with a Nikon DS-Vi1 digital camera (Nikon Instruments) connected to a 318 computer. The area of each field (0.07 mm 2 ) was standardized using NIS Elements BR 3.22 319 imaging software (Nikon Instruments). After electrophoresis, the proteins in the gel were transferred to a nitrocellulose membrane, the 331 blots were blocked with 5% nonfat dry milk in PBS containing 0.1% Tween-20 for 1 hours at room 332 temperature. Membranes were incubating overnight with primary antibodies anti EGFR, VEGF, 333 MMP-1 and MMP-9, (Santa Cruz Biotechnology, CA, USA) and GAPDH ((Santa Cruz 334 Biotechnology) as endogenous control, followed by incubation with a secondary antibody 335 conjugated to horseradish peroxidase (Santa Cruz Biotechnology). The detection of the proteins on 336 the membrane was performed using the Clarity Western ECL Substrate kit (Bio-rad). The signals 337 were captured using the Alliance Mini (UVITEC Cambridge) system. The UVITEC software 338 carried out the quantization of the bands and the intensity of each band of interes) was normalized 339 comparing it to the housekeeping GAPDH protein, used as loading control. Subsequently, the 340 intensity of each tested band was compared to negative controls. 341
Statistical analysis 342
All results were expressed as mean values ± SD. Differences between the groups were analyzed by 343 one-way analysis of variance (ANOVA) tests and p values were determined using the Bonferroni 344 test. Statistical analyses were performed using the SPSS 16 package (SPSS Inc., Chicago, IL, USA 
